Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Real-time Estimate Cboe BZX
Other stock markets
 12:26:25 2024-05-17 pm EDT 		5-day change 1st Jan Change
3.145 USD -0.47% Intraday chart for Revance Therapeutics, Inc. -5.72% -64.39%
May. 10 Needham Adjusts Price Target on Revance Therapeutics to $12 From $18, Maintains Buy Rating MT
May. 10 Piper Sandler Cuts Price Target on Revance Therapeutics to $11 From $20, Maintains Overweight Rating MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. News Revance Therapeutics, Inc.
  5. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW